Identification and Quantitative Analysis of 2-Fluoromethamphetamine and Its Metabolites in Human Urine

被引:2
|
作者
Ishii, Ayumu [1 ]
Sato, Kazuki [2 ]
Kusakabe, Kosuke [1 ]
Kato, Noriyuki [1 ]
Wada, Takeshi [2 ]
机构
[1] Kanagawa Prefectural Police Headquarters, Sci Crime Lab, Naka Ku, 155-1 Yamashitacho, Yokohama, Kanagawa, Japan
[2] Tokyo Univ Sci, Fac Pharmaceut Sci, 2641 Yamazaki, Noda, Chiba, Japan
关键词
METHAMPHETAMINE; ISOZYMES; FLUORINE; ANALOGS; MDMA;
D O I
10.1093/jat/bkac026
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Various synthetic drugs have appeared over the past years across the world, and phenethylamine derivatives are among them; indeed, aromatic fluoro analogs of methamphetamine and amphetamine have been in the illicit drug market since the early 2000s. Although they are currently widely abused across the world, little information is available on their metabolism and toxicology. Recently, we came across an alleged 2-fluoromethamphetamine (2-FMA) drug abuse case. The urine obtained from the alleged abuser was analyzed as part of a criminal investigation. 2-FMA, 2-fluoroamphetamine (2-FAP) and some related compounds were detected by liquid chromatography-tandem mass spectrometry. In forensic science, both an "unchanged" drug and its metabolite(s) need to be detected in urine to verify the illicit drug use. Notably, the detection of 2-FAP, which is a plausible 2-FMA metabolite, is insufficient as evidence of 2-FMA use because 2-FAP is widely available and may be present as such in taken liquids. In this study, we synthesized analytical standards for N-hydroxy 2-FMA (N-OH-2-FMA) and two diastereomers of 2-fluoroephedrine, which are plausible metabolites of 2-FMA. Using these standards, the urine specimen was found to contain N-OH-2FMA and one diastereomer of 2-fluoroephedrine; moreover, the concentrations of these compounds were successfully determined. The results of our study suggest that N-hydroxylation and aliphatic hydroxylation are the characteristic metabolic pathways of 2-FMA compared with that of methamphetamine. This evidence indicates that both N-OH-2-FMA and 2-fluoroephedrine are plausible candidates as analytical targets for drug-use certification in forensic science.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 50 条
  • [2] Identification of (2-aminopropyl)benzofuran and its metabolites in human urine
    A. V. Labutin
    A. Z. Temerdashev
    [J]. Journal of Analytical Chemistry, 2017, 72 : 770 - 776
  • [3] Identification of (2-aminopropyl)benzofuran and its metabolites in human urine
    Labutin, A. V.
    Temerdashev, A. Z.
    [J]. JOURNAL OF ANALYTICAL CHEMISTRY, 2017, 72 (07) : 770 - 776
  • [4] Quantitative analysis of HBY097 and its metabolites in human serum and urine by HPLC
    Agarwal, VK
    Krol, GJ
    Krone, V
    Roberts, D
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 16 (07) : 1195 - 1203
  • [5] IDENTIFICATION OF 2 NEW SUPROFEN METABOLITES IN HUMAN URINE
    WU, WN
    MASUCCI, JA
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1994, 12 (04) : 569 - 571
  • [6] QUANTITATIVE-ANALYSIS OF CINOXACIN METABOLITES IN HUMAN-URINE
    SAKANO, T
    MASUDA, S
    AMANO, T
    [J]. CHEMOTHERAPY-TOKYO, 1980, 28 : 139 - 142
  • [7] Identification of human hexahydrocannabinol metabolites in urine
    Schirmer, Willi
    Auwaerter, Volker
    Kaudewitz, Julia
    Schuerch, Stefan
    Weinmann, Wolfgang
    [J]. EUROPEAN JOURNAL OF MASS SPECTROMETRY, 2023, 29 (5-6) : 326 - 337
  • [8] IDENTIFICATION OF 2 NEW METABOLITES OF HYDRALAZINE FROM HUMAN URINE
    ZAK, SB
    GILLERAN, TG
    KARLINER, J
    LUKAS, G
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1974, 17 (03) : 381 - 382
  • [9] IDENTIFICATION AND MEASUREMENT OF 2 NEW METABOLITES OF NALTREXONE IN HUMAN URINE
    CONE, EJ
    GORODETZKY, CW
    DARWIN, WD
    CARROLL, FI
    BRINE, GA
    WELCH, CD
    [J]. RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1978, 20 (03): : 413 - 433
  • [10] ANALYSIS OF DICLOFENAC AND 4 OF ITS METABOLITES IN HUMAN URINE BY HPLC
    SAWCHUK, RJ
    MALONEY, JA
    CARTIER, LL
    RACKLEY, RJ
    CHAN, KKH
    LAU, HSL
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (05) : 756 - 762